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Abstract
BACKGROUND 
Schizophrenia spectrum disorders impact functioning, reduce quality of life and 
increase the risk of physical illness and premature mortality. Nutritional 
intervention studies aimed at decreasing body weight have demonstrated efficacy 
in improving metabolic outcomes; however, few studies have explored the impact 
of interventions designed to modify diet on mental health outcomes.
AIM 
To synthesize the existing experimental studies of adjunctive diet modification as 
an intervention in the treatment of psychotic disorders, analyze findings related to 
effectiveness and safety, highlight knowledge gaps and limitations, and set 
forward recommendations for future research studies.
METHODS 
An extensive a priori search strategy was developed and the databases Embase, 
Embase Classic, Ovid MEDLINE were searched. Screening and data extraction 
were completed in duplicate. Studies included in this analysis were experimental 
studies of an adjunctive dietary intervention (overall dietary pattern or education 
on dietary change) for treatment of schizophrenia spectrum disorders. No 
restrictions were placed on control groups or blinding. The studies were required 
to report a mental health outcome.
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Twenty-five clinical trials were identified, along with two additional protocols 
and two meta-analyses. Nineteen of the clinical trials reported improvement in 
one or more mental health domain including psychosis symptoms, cognition, and 
quality of life. A high level of heterogeneity was found with respect to patient 
population, intervention, and study design. All of the studies included lifestyle or 
psychosocial components in addition to dietary modification. The nutrition advice 
provided to participants was poorly described overall and compliance was not 
assessed. The studies that showed benefit tended to have a smaller sample size 
and were less likely to be randomized but were more likely to use a group 
delivery intervention.
CONCLUSION 
Further research assessing effectiveness and efficacy of clearly reported dietary 
interventions is warranted, especially those using rigorous methodology, 
modifying diet in isolation and assessing participant compliance.
Key words: Nutrition; Psychosis; Schizophrenia; Diet
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Core tip: While guidelines exist related to the role of nutrition interventions in the 
management of obesity and physical comorbidities in patient with schizophrenia spectrum 
disorders, there is limited clinical use in the management of mental health symptoms. This 
systematic review identified and analysed the findings of 25 clinical trials which modified 
participant diet and measured a mental health outcome. Nineteen reported improvement in 
one or more domain; however, many used additional interventions in combination with 
nutrition, and failed to report a detailed intervention protocol or assess compliance, 
limiting the conclusions that can be drawn. Further research is warranted using rigorous 
methodology.
Citation: Aucoin M, LaChance L, Clouthier SN, Cooley K. Dietary modification in the 





Schizophrenia spectrum disorders (SSD) include schizophrenia, schizoaffective 
disorder, and other psychotic disorders. The etiology is largely unknown and likely 
multifactorial with genetic, biological, and social factors implicated. SSD symptoms 
include positive symptoms (including delusions and hallucinations), negative 
symptoms (including social withdrawal and apathy), depression, and cognitive 
symptoms. While many theories exist, these symptoms may be attributed to 
imbalances in neurotransmitters and their receptors, dysregulation of other 
neurochemicals such as brain derived neurotrophic factor (BDNF), immune 
dysregulation, neuro-inflammation, and mitochondrial and metabolic dysfunction[1-3]. 
Treatment of SSD includes a combination of pharmaceutical and psychosocial 
interventions including anti-psychotic medications.
Individuals with psychotic disorders are at significantly elevated risk of medical 
comorbidities, ultimately resulting in an estimated 8 to 20-year reduction in 
lifespan[4,5]. Several factors contribute to increased risk of mortality such as 
socioeconomic status, increased tobacco use, low quality diet, and metabolic 
complications caused by antipsychotic medication[6-10].
Guidelines and programs exist to support SSD patients in dietary choices to manage 
weight and physical illness; however, nutritional guidelines for the treatment of 
psychiatric symptoms do not exist. Nutritional psychiatry is a relatively recent field, 
studying the effects of nutrients on mental illness incidence and progression. An 
expanding body of evidence including observational[11], mechanistic, and intervention 
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studies[12,13] demonstrates a role of dietary constituents and patterns in the prevention 
and treatment of mental illnesses, although research in SSD is relatively limited.
Health care providers often accurately report obstacles faced by patients with SSD 
in the implementation of dietary interventions. Obstacles include motivational and 
cognitive barriers, poverty, as well as psychotic symptoms[14]. However, dietary 
intervention trials designed to improve aspects of physical health have documented 
feasibility and acceptability among SSD patients. One diet intervention study 
demonstrated an increased vegetable intake and decreased intake of discretionary 
foods and calories in first episode psychosis patients[5]. Another study involving 
participants with severe mental illness demonstrated improvements in diet quality 
and cardiovascular disease risk factors following a Mediterranean diet intervention[15].
Although fewer in number, some intervention studies have assessed mental health 
symptoms as primary or secondary outcomes. The purpose of the present systematic 
review is to synthesize the existing experimental studies of dietary modification as 
adjunctive treatment for psychotic disorders. We sought to analyze findings related to 
mental health outcomes (efficacy) and safety, highlight knowledge gaps and 
limitations, and set forward recommendations for future research studies.
MATERIALS AND METHODS
An extensive a priori search strategy was developed by an experienced medical 
information specialist through an iterative process, which included over 300 search 
terms. Supplementary material appendix 1 contains the full search strategy. The search 
was executed in Embase, Embase Classic, and Ovid MEDLINE on January 6, 2017 and 
updated on April 15, 2018 with the removal of a small fraction of search terms that had 
failed to yield useful results in the initial search (see appendix 1 for details). No limits 
were placed on language, publication status, or year of publication.
Eligible studies included experimental studies with an intervention that attempted 
to manipulate participants’ overall dietary pattern (e.g., “healthy diet”, diet 
counselling, nutrition education), not just an individual type of food, dietary 
constituent or isolated component (e.g., supplement studies, low carbohydrate diets, 
gluten-free diets). The studies included participants with psychotic disorders. No 
restrictions were placed on blinding or the presence of a control group. Studies were 
required to assess a mental health outcome; studies that measured only physical health 
outcomes were not eligible.
Title and abstract screening were completed, based on the above criteria, in 
duplicate using Abstrackr, an online open-source program that facilitates rapid 
screening decisions and concurrent tagging of results. Disagreement was resolved by 
consensus by the two principle investigators (Monique Aucoin and Laura LaChance). 
Studies that failed to meet inclusion criteria on full text review were excluded. Data 
was extracted in duplicate using a piloted template. The data extracted included: 
author name, year of publication, geographic location, presence of control group, use 
of randomization, use of blinding, study population, inclusion of individuals with 
additional psychiatric illnesses, sample size, intervention description, method of 
intervention delivery (group or individual), additional interventions provided 
simultaneously, mental health outcome reported, change in outcome, whether the 
mental health outcome was identified as the primary outcome, weight or other 
physical health outcome and adverse events. Because of the significant heterogeneity 
of the populations, interventions and outcomes, meta-analysis was not attempted. 
Studies were grouped based on whether or not a positive mental health outcome was 
reported, the primary outcome of interest. χ2 test was used to assess for significance in 
the differences between these groups of studies based on study design and factors 
which may contribute to bias.
The search strategy was initially designed for the conduct of a larger scoping review 
on the topic of dietary factors and psychosis which has been previously published[16].
On January 20, 2020, a search update was completed for any additional studies that 
met criteria for the present systematic review. Because this update was completed 
exclusively for the present review, a modified search string using the following terms 
was executed: (Diet or Dietary or Nutrition or food) and (psychosis or psychotic or 
schizophrenia).
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RESULTS
The initial search and updates identified 76889 results, which were reduced to 55330 
after de-duplication. Using Abstrackr to facilitate screening allowed study authors to 
manually screen slightly less than 50% of results (26053), relying on the artificial 
intelligence feature of the program to screen the remaining articles. 1290 articles were 
assessed in full-text form with 822 meeting criteria for the scoping review. Of these, 27 
manipulated the dietary pattern of participants and met criteria for inclusion in the 
present systematic review. The update of the search January 2020 yielded 356 results, 
of which two met criteria for inclusion (Figure 1).
Description of studies
The majority of the studies were published between 2015 and 2019 (Figure 2).
Overall, most of the studies were published in the United Kingdom and Europe 
followed by North America with the remaining published in Australia, Asia, and 
South America.
Methodology
Three publications described study protocols. The results of one of these protocols 
were described in another publication. Two studies were meta-analyses. The 
remaining twenty-five studies were completed clinical trials. Of those, four studies 
employed both blinding and randomization. An additional five studies used a control 
group and randomization but no blinding. Another six studies used a control group 
but lacked randomization and blinding. The remaining ten trials were completed with 
no control group (Table 1)[17-41].
Sample size
The average sample size of the completed studies was 171.8; however, there was 
significant heterogeneity (SD = 191.5, range: 8 to 770).
Duration
The mean duration was 33.4 wk (SD = 31). Most studies used an intervention which 
lasted between four months and one year. Two studies lasted two years or longer.
Interventions
The details of the interventions themselves were generally poorly described. Most of 
the interventions consisted of nutritional education that focused on healthy diet habits. 
Some programs reported more specific macronutrient recommendations while other 
emphasized general concepts like meal planning and goal setting. Three interventions 
involved following specific energy-restricted diets. An additional three interventions 
mentioned education about calories. The interventions were mainly group-based. Five 
trials implemented interventions that had both individual and group components and 
five trials consisted of individual interventions only. It was unclear if the interventions 
were individual or group-based in two of the studies. Nearly all studies failed to 
identify the qualifications or training of the individual(s) delivering the interventions.
In most of the studies, the participants continued to take their psychiatric 
medications. All studies supplemented the dietary interventions with exercise and/or 
psychosocial interventions such as motivational interviewing, smoking cessation, or 
peer support. The additional interventions that were used alongside diet are displayed 
in Figure 3.
Population
Seventeen of the twenty-five studies recruited patients with a diagnosis of 
schizophrenia, SSD, or psychosis. Two of the studies included participants who were 
taking an antipsychotic medication, regardless of their specific psychiatric diagnosis. 
Ten of the studies included participants diagnosed with schizophrenia in combination 
with other mental illnesses such as bipolar disorder, anxiety disorder, major 
depressive disorder, or personality disorders. Of those, one study required a co-
morbid substance-use disorder diagnosis. One study was completed on healthy 
children who were followed to monitor the development of schizotypal personality 
traits or antisocial behaviour at ages 17 and 23.
Most of the interventions were carried out in an adult population. One study 
recruited teenagers (ages 13-17), one recruited youth experiencing early psychosis and 
one study included children (ages 3-5).
Eight of the studies required participants to have a weight concern such as recent 
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Table 1 All included studies










Studies with one or more positive outcomes
Usher et al[17], 
2019
TAU None Youth, early psychosis 33 Behaviour intervention teaching mindfulness 
meditation, cooking classes, supermarket 
trips, fast-food learning, nutrition education, 
exercise, moderated group discussion to 
facilitate healthier living
Yes 12 Positive symptoms 
(Quick Scale for the 





ImprovementOsborn et al[18], 
2018
TAU Randomized, single 
blind
Bipolar disorder (50%), 
schizophrenia (30%) or psychosis 
(20%); elevated cholesterol and 1 
+ modifiable risk factors for CVD
327 Manualized intervention to decrease 
cholesterol and CVD risk: Adherence to 







Chronic schizophrenia 45 Lifestyle program including nutrition, meal 
planning, walking/running group, smoking 
cessation, MI. individual and group 
components
No 120 QOL (WHOQoL) NullHjorth et al[19], 
2017
None None
Newly diagnosed schizophrenia 123 QOL (WHOQoL) Improvement
QOL (WHOQoL) ImprovementJuel et al[20], 2017 None None Psychotic disorder, affective 
disorder, anxiety disorder, or 
developmental disorder with 
comorbid substance use or 
dependence; 12.5% SSD
64 Nutrition, exercise and smoking cessation 
program. Includes health diet habits, reading 
nutrition labels, macronutrient 






TAU None Schizophrenic, schizoaffective or 
bipolar, treated with 
antipsychotic drug (67% SSD); 
BMI > 25
332 Group nutrition education and exercise 
sessions
No 12 QOL (SF-36) Improvement
Negative (PANSS) ImprovementFarhat et al[22], 
2016
None None Schizophrenia 8 Group educational program including 
nutritional balance, meal planning, 





Waitlist None SMI including psychotic 
disorders; weight concern








None None Schizophrenia 14 Group educational program/ psychosocial 
program including schizophrenic disease, 
treatments, relationships to family, diet, 
social issues, relaxation
Yes 15
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TAU Treatment centers 
randomized
Patients with severe mental 
illness (primarily SSD), inpatient
130 Group diet and exercise intervention: 
Lifestyle intervention to change the 
obesogenic environment within residential 





None None Schizophrenia-spectrum 25 Group healthy lifestyle group, walking 
group, grocery shopping







Bralet et al[27], 
2013
None None Schizophrenia 10 Group nutrition education, cognitive 





Biologic (BDNF) ImprovementKuo et al[28], 
2012
TAU None Schizophrenia 63 Group weight reduction program including 
food recommendations (more vegetables and 






QOL (15D) NullPorsdal et al[29], 
2010
TAU None Schizophrenia or bipolar I, taking 
psychotropic medication








None None DMS-IV Axis I or II diagnosis; 
18% SSD
76 Individualized health promotion program: 
health eating, exercise social inclusion, 







Doorly et al[31], 
2009
None None Schizophrenia 9 Nutrition (avoid high fat food, increase fiber, 
strategies for weight loss), exercise and stress 
management coaching














TAU None Schizophrenia 67 Calorie-restricted diet; reduction in saturated 
fat and sugar, increase in fruit and 
vegetables. Individual delivery








Raine et al[34], 
2003
TAU Randomized Children aged 3-5 years, no 
diagnosis
438 Group nutrition, education and physical 
exercise program: structured nutrition 
program provided the children with milk, 
fruit juice, a hot meal of fish or chicken or 
mutton, and a salad each day
Yes 104
Improvement
Aucoin M et al. Dietary modification in schizophrenia spectrum disorders
WJP https://www.wjgnet.com 193 August 19, 2020 Volume 10 Issue 8
questionnaire)
Aquila et al[35], 
2000
None None Inpatients with severe persistent 
mental illness taking atypical 
antipsychotics
32 Group diet intervention to decrease fat, 
calories, sugar, snacking
No 78 Negative (subjective 
assessment)
Improvement
Studies without positive outcomes
Depression NullHolt et al[36], 
2019
TAU Randomization Schizophrenia, schizoaffective 
disorder or first-episode 
psychosis, antipsychotic 
medication, BMI > 25 or concern 
about weight
412 Education on nutrition, physical activity and 














Psychotic disorder, mood 
disorder, personality disorder, 
anxiety, substance use disorder, 
developmental disorder or 
psychiatric comorbidity; 74% 
SSD; inpatient
770 Diet and exercise lifestyle intervention to 
adjust obesogenic environment (offer low-fat 
cheese, whole wheat alternatives, less 
sweets, smaller portions of snacks, fresh 
rather than canned vegetables) Includes 





Gym membership Randomized Major depressive disorder, 
schizoaffective disorder, or 
schizophrenia; 46% SSD
343 Individual nutrition, MI, fitness goal setting Yes 52 Depressive Symptoms 
(CESD)
Null
Detke et al[39], 
2016
Single 15-min 
session of basic 
information
None Schizophrenia or Bipolar I 203 Individual intense behavioural weight 
counseling – nutrition education, pedometer, 
motivational enhancement, guidance on 
caloric restriction, low-fat, nutrient dense 
foods in moderate portion sizes















disorder or persistent delusional 
disorder, abdominal obesity
428 Individual lifestyle program teaching 
healthy diet, cooking, smoking cessation, 






Jones et al[41], 
2007
None None Taking antipsychotic medication 50 Group psychoeducation and physical 
activity program including nutrition, 
budgeting, cooking, goal setting
No 10 QOL (SF-36) Null
BACS: Brief Assessment of Cognition in Schizophrenia; BDNF: Brain-derived neurotrophic factor; BMI: Body mass index; BPRS: Brief psychiatric rating scale; CDSS: The Calgary Depression Scale for Schizophrenia; CESD: Center for 
Epidemiological Studies Depression scale; CVD: Cardiovascular disease; GAF: Global Assessment of Functioning; MANSA: Manchester Short Assessment of Quality of Life; MARS: Medication Adherence Rating Scale; MI: Motivational 
interviewing; PANSS: The Positive and Negative Syndrome Scale; QOL: Quality of life; SANS: Scale for the Assessment of Negative Symptoms; SAPS: Scale for the Assessment of Positive Symptoms; SF-12: 12-Item Short Form Health 
Survey; SF-36: The 36-Item Short Form Health Survey questionnaire; SMI: Severe mental illness; SSD: Schizophrenia spectrum disorders; STICCS: Subjective Scale to Investigate Cognition in Schizophrenia; TAU: Treatment as usual; 
WHOQoL: World Health Organization Quality of Life –Brief.
weight gain or a body mass index (BMI) or waist circumference above a certain level. 
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Figure 1  PRISMA flow chart.
Figure 2  Distribution of studies based on year of publication.
Three studies involved participants in a supportive housing or clinical care facility, the 
remaining studies were completed with community-dwelling participants.
Outcomes
Of the 27 study protocols described, twelve were designed with mental health 
symptoms as the primary outcome. The remaining studies described the mental health 
outcomes as secondary or exploratory.
Outcome measures included quality of life, psychosis symptoms, cognitive 
symptoms, self-esteem, functioning, depression, mental healthcare service utilization 
and levels of the biomarker BDNF. Nineteen studies reported at least one positive 
mental health outcome (Figure 4, Table 1). While several studies reported changes in 
total psychosis symptoms, three reported improvements in negative symptoms and 
one in positive symptoms. The prospective intervention trial that assessed prevention 
of psychotic symptoms in children reported a decrease in positive symptoms at the 
later outcome assessment[34]; however, given that this study’s design was significantly 
different compared to the others in this review, these results may be considered 
separately from the other studies reviewed.
Studies that did not report a positive mental health outcome were more likely to 
include 200 or more participants, use a control group or randomization, or include 
participants with diagnoses other than schizophrenia. They were more likely to 
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Figure 3  Additional interventions used alongside dietary modification in 25 studies.
Figure 4  Direction of findings for specific outcomes. Psy: Psychotic symptoms; QoL: Quality of life; Funct: Functioning; Dep: Depression; Med/use: 
Medication use or mental health care utilization; Esteem: Self-esteem/self-efficacy/perceived health.
involve one-on-one intervention rather than group intervention. Compared with those 
showing benefit, they were less likely to cite mental health symptoms as a primary 
outcome and less likely to report positive findings in an outcome related to body 
weight. The differences between studies reporting a benefit to mental health outcomes 
and those that did not are reported in Table 2. The differences in sample size, group vs 
individual intervention format and, randomization achieved statistical significance.
With respect to duration of the effect, one study reported that positive mental health 
and weight outcomes persisted at a six month follow up assessment[32], the remainder 
did not report on long term outcomes.
A meta-analysis of six lifestyle intervention studies, including 289 participants, 
evaluated changes in levels of peripheral serum and plasma BDNF in patients with 
SSD and reported some positive findings compared to a control group[42]. A meta-
analysis of 25 lifestyle intervention studies, including 1518 SSD participants, reported 
improvement in depression symptoms[43].
In addition to assessing mental health outcomes, 18 studies assessed physical health 
outcomes such as body weight, blood pressure, serum cholesterol, waist 
circumference, oral glucose tolerance, serum cytokine levels, and glycosylated 
haemoglobin. Nine of 18 studies found improvements in at least one physical measure 
with body weight, BMI and waist circumference most likely to benefit. It should be 
noted, that this represents a subset of the research on this topic; studies assessing 
exclusively physical outcomes were excluded from this review.
Adverse events
Adverse events were not generally reported. One study commented on adverse events 
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Table 2 Characteristics of studies that reported benefit in mental health outcomes and those that did not
Number of studies reporting 
benefit (%)




Studies with greater than 200 participants 4 of 19 (21) 5 of 6 (83) 0.00559
Studies that included patients with non-SSD diagnoses (e.g., Depression, 
Bipolar, substance use disorder)
8 of 19 (42) 4 of 6 (67) 0.29380
Studies with an individual intervention component 2 of 19 (11) 3 of 6 (50) 0.03509
Studies designed with primary outcome related to mental health 9 of 19 (47) 2 of 6 (33) 0.54599
Studies that used a control 10 of 19 (53) 5 of 6 (83) 0.18081
Studies that used randomization 3 of 19 (16) 4 of 6 (67) 0.01553
Studies with positive finding in an outcome related to body weight 7 of 10 (70) 1 of 4 (25) 0.12428
that were medication-induced and not attributed to the intervention[39]. Another trial 
noted an increase in psychotropic medication use over the course of the assessment 
period[20]. An additional trial commented on deterioration of mental well-being in the 
intervention group[37]. Finally, one of the studies found that there were three deaths in 
the intervention group and they were not considered a result of the intervention; any 
other adverse events were similar between the treatment and the control groups[36].
DISCUSSION
This systematic review identified the clinical trials which have attempted to modify 
dietary patterns in patients with SSD and reported mental health outcomes in response 
to treatment. The results suggest that these interventions may have promise for 
improving mental health symptoms in SSD patients. However, there are significant 
limitations to these studies and opportunities for further research.
Twenty-one of 27 primary and secondary research studies reported significant 
improvement in terms of quality of life, symptom improvement, increased 
functioning, decrease mental healthcare utilization and/or improved cognition. 
Studies with positive findings were generally less likely to include other patient 
populations (non-SSD), were more likely to have a group component; however, they 
tended to include smaller sample sizes and were less likely to be randomized.
Adverse events were often not reported and if they were reported, they were not 
attributed to the dietary intervention itself. Two studies reported worsening mental 
health in response to treatment. One study[20] noted that participants had to increase 
their use of medication during the trial. The medication that was typically increased 
was quetiapine (Seroquel), which is also used as a sleep aid. The authors theorized that 
the increase in medication may be due to sleep issues rather than increasing 
psychiatric symptoms as the participants’ sleep did worsen in the trial, possibly 
attributed to the various stages of withdrawal from substance use. The other study[37] 
noted that Quality of Life decreased in the intervention group. They attributed this to 
significant differences in levels of depression at baseline (non-optimal randomization) 
and a possible regression towards the mean. Furthermore, although the decrease in 
quality of life was statistically significant, it may not have been clinically relevant as it 
was a decrease of 1.5 points, on a scale with a range of 12-84 points.
Many of the studies utilized a group setting for the intervention. There is significant 
research suggesting a role of peer support and motivation in behavioural change[44,45]. 
In this review, studies using group interventions were more likely to report positive 
findings. Group delivery of interventions has the added benefit of cost effectiveness[46].
A significant limitation of this body of research is the generally small sample size 
and low methodological quality; few studies used randomization, blinding, or control 
groups. However, the most significant limitation is that all studies used multi-modal 
interventions rather than diet alone. These included exercise, psychosocial 
interventions, and smoking cessation in addition to medication. As the first two have 
significant evidence for a role in promoting improved mental health in SSD, it creates 
difficulty in understanding the exact role that diet modification may have played in 
achieving the outcomes reported.
Additionally, many of the studies were designed to test interventions for weight 
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loss or other physical conditions such as hypertension, dyslipidemia and glucose 
dysregulation. Mental health outcomes were secondary or exploratory in most of the 
studies. As a result, studies may have been statistically powered to detect changes in 
the primary physical outcomes and not the mental health outcomes.
A significant limitation of this body of evidence is in the reporting of the diet 
interventions tested. Nineteen studies described the intervention as “a healthy diet” or 
“nutrition education”. While some studies provided details about the goals of the 
intervention (such as increased vegetable intake, decreased saturated fat intake), the 
majority of studies did not. Scientific understanding of a “healthy diet” has changed 
over time. For example, the American Dietary Guidelines removed cholesterol as a 
nutrient of concern in 2015 due to lack of evidence that dietary cholesterol impacts 
serum cholesterol levels[47]. However, previous guidelines had advised patients on 
limiting exposure to this nutrient. While certain dietary factors such as vegetables and 
fiber have been consistently viewed as healthy, fats and carbohydrates have 
experienced shifting attitudes over the previous decades[48]. As a result, studies 
designed at different times may have recommended significantly different 
macronutrient ratios. In addition to the role of macro- and micro-nutrients, a body of 
evidence has identified inflammation, oxidative stress, glycemic balance, food 
sensitivities, and the gut microbiome as intermediate factors between diet and mental 
health[49]. These various factors make it difficult to interpret the studies included in this 
review. It is possible that unique interventions with differing impacts on these 
pathophysiologic mechanisms contributed to the differing outcomes between studies. 
Future research may benefit from application of reporting checklists designed to 
improve the reporting of interventions[50]. A recent systematic review of methodology 
reporting in lifestyle interventions among people with psychosis also found generally 
incomplete reporting and put forward a recommendation for use of the CONSORT 
statement in future publications[51].
While it has been demonstrated that diet patterns in this patient population can be 
changed in response to nutrition education and counseling, it is widely acknowledged 
that this is challenging[14]. The lack of compliance data in the studies using educational 
programs and diet counselling creates significant difficulty in interpreting this body of 
evidence. It is possible that variability of compliance with the dietary interventions 
across studies could in part explain differing outcomes reported. Four studies included 
the provision of some or all of the participants’ food intake and thus had a higher 
degree of control. These included the prospective prevention study in children and 
three studies which took place in in-patient settings. Although these studies involved 
modification to the available food options, there was still a degree of control exercised 
by participants with respect to the food they consumed. Of note, three of these four 
studies reported benefit.
Further research should include assessment of compliance. In designing further 
studies, researchers could consider subjective assessment tools such as the 
Mediterranean Diet score or Alternative Healthy Eating Index[52] or objective 
assessment approaches such as plasma vitamin C and serum carotenoids[53] or 
metabolomic analysis[54]. While speculative, the non-significant association found 
between studies showing benefit in both mental health and physical health outcomes 
could be related to participant compliance. Alternatively, the improvement in mental 
health symptoms may be related to changes in weight, as a bidirectional relationship 
between the two is known[55]. In the absence of information related to intervention 
uptake, the studies showing a lack of change to mental health outcomes cannot 
conclude that diet does not impact psychosis and other mental health outcomes but 
rather that the educational intervention provided was not able to elicit these changes.
The results of this body of evidence suggest that diet may be a modifiable target for 
the treatment of psychotic disorders alongside treatment as usual. Dietary 
interventions were associated with improvements in psychosis symptoms, quality of 
life, and functioning in some studies. Improved nutrition has also been shown to 
improve the physical health in a population at high risk of medical illness[5]. There are 
studies reporting no effect of dietary intervention. These inconsistencies may be 
attributable to heterogeneity in dietary interventions (including the multi-modal 
nature), unclear participant compliance with educational interventions and 
heterogeneous participant populations.
Nutritional interventions have a few clear benefits. They are relatively low in cost, 
low in risk, and have the potential to benefit the highly prevalent and costly physical 
comorbidities of schizophrenia spectrum disorders. When interpreted in combination 
with the more advanced research in other psychiatric populations, such as randomized 
controlled trial of adjunctive dietary interventions in major depressive disorder, there 
is justification for more research in this area.
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Future studies should aim to examine adjunctive dietary modification without 
manipulation of other health behaviours, assess compliance using subjective or 
objective methods, include more homogeneous patient populations, identify mental 
health symptoms as primary outcomes and be powered accordingly. In addition, high 
quality experimental studies with a control group, blinding, and randomization are 
needed in this area of research alongside continuing research exploring effectiveness 
in real world scenarios. Lastly, in reporting on these studies, clearer description of the 
experimental dietary interventions would assist in interpreting results, duplication of 
findings, and guiding further research.
ARTICLE HIGHLIGHTS
Research background
Schizophrenia spectrum disorders (SSD) impact functioning, reduce quality of life and 
increase the risk of physical illness and premature mortality. Several observational and 
preclinical studies suggest a role of diet in the development and progression of SSD 
and rigorous clinical trials designed to assess the impact of adjunctive diet 
interventions in patients with major depression have reported benefit.
Research motivation
Nutritional intervention studies aimed at decreasing body weight have demonstrated 
efficacy in improving metabolic outcomes; however, few studies have explored the 
impact of interventions designed to modify diet on mental health outcomes. 
Systematic review of this body of literature has not been previously conducted.
Research objective
This systematic review sought to synthesize the existing experimental studies of 
adjunctive diet modification as an intervention in the treatment of psychotic disorders, 
analyze findings related to effectiveness and safety, highlight knowledge gaps and 
limitations, and set forward recommendations for future research studies.
Research methods
An extensive a priori search strategy was developed and the databases Embase, 
Embase Classic, Ovid MEDLINE were searched. Screening and data extraction were 
completed in duplicate. Studies included in this analysis were experimental studies of 
an adjunctive dietary intervention (overall dietary pattern or education on dietary 
change) for treatment of SSD. No restrictions were placed on control groups or 
blinding. The studies were required to report a mental health outcome.
Research results
Twenty-five clinical trials were identified, along with two additional protocols and 
two meta-analyses. Of the 25 clinical trials, four employed both blinding and 
randomization. Five studies used a control group and randomization but no blinding 
while another six studies used a control group but lacked randomization and blinding. 
The remaining ten trials were completed with no control group. The average sample 
size was 171 participants and the average duration was 33 wk. The interventions 
consisted primarily of nutritional education; however, the nutrition advice provided to 
participants was poorly described overall and compliance was not assessed. All of the 
studies included lifestyle or psychosocial components in addition to dietary 
modification. Of the 27 protocols, twelve were designed with mental health symptoms 
as the primary outcome. A high level of heterogeneity was found with respect to 
patient population, intervention, and study design. Nineteen of the clinical trials 
reported improvement in one or more mental health domain including psychosis 
symptoms, cognition, and quality of life. The studies that showed benefit tended to 
have a smaller sample size and were less likely to be randomized but were more likely 
to use a group delivery intervention. Adverse events were not generally reported.
Research conclusions
The findings of this systematic review suggest that adjunctive diet interventions may 
be useful in the management of mental health symptoms in SSD; however, limitations 
in the existing research preclude clear conclusions.
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Research perspectives
Further research assessing effectiveness and efficacy of clearly reported dietary 
interventions is warranted, especially those identifying mental health symptoms as 
their primary outcome, using rigorous methodology (control group and blinding), 
modifying diet in isolation from other health behaviours and assessing participant 
compliance.
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